» Articles » PMID: 33880243

MRI Virtual Biopsy of T2 Hyperintense Breast Lesions

Overview
Specialty Radiology
Date 2021 Apr 21
PMID 33880243
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A wide variety of benign and malignant breast processes may generate hyperintense signal at T2-weighted magnetic resonance imaging (MRI). MRI has been traditionally used in the pre-treatment planning of breast cancer, in assessing treatment response and detecting recurrence. In this comprehensive review, we describe and illustrate the MRI features of a few common and uncommon T2 hyperintense breast lesions, with an emphasis on MRI features that help to characterize lesions based on morphological features, specific appearances on T1-and T2-weighted imaging, and enhancement characteristics on the dynamic post-contrast phase that are either diagnostic or aid in narrowing the differential diagnosis.

Citing Articles

The potential role of breast MRI in evaluation of triple-negative breast cancer and fibroadenoma of less than 3 cm.

Wei Z, Chen X, Yang Y, Yang L, Ma X Transl Cancer Res. 2024; 13(8):4042-4051.

PMID: 39262467 PMC: 11384317. DOI: 10.21037/tcr-24-498.


Study of the Genomic Characterization of Antibiotic-Resistant Isolated From Iraqi Patients with Urinary Tract Infections.

Mouhammed K, Gdoura R Indian J Microbiol. 2024; 64(2):457-466.

PMID: 39011020 PMC: 11246310. DOI: 10.1007/s12088-023-01123-3.


Unveiling the Intricacies: A Comprehensive Review of Magnetic Resonance Imaging (MRI) Assessment of T2-Weighted Hyperintensities in the Neuroimaging Landscape.

Dhabalia R, Kashikar S, Parihar P, Mishra G Cureus. 2024; 16(2):e54808.

PMID: 38529430 PMC: 10961652. DOI: 10.7759/cureus.54808.


MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes.

Bissell M, Keshavarsi S, Fleming R, Au F, Kulkarni S, Ghai S Breast Cancer Res Treat. 2024; 205(1):159-168.

PMID: 38305940 DOI: 10.1007/s10549-023-07239-w.


Relaxation-Diffusion T2-ADC Correlations in Breast Cancer Patients: A Spatiotemporally Encoded 3T MRI Assessment.

Otikovs M, Nissan N, Furman-Haran E, Anaby D, Agassi R, Sklair-Levy M Diagnostics (Basel). 2023; 13(23).

PMID: 38066757 PMC: 10705897. DOI: 10.3390/diagnostics13233516.

References
1.
Mun S, Ko E, Han B, Shin J, Kim S, Cho E . Breast metastases from extramammary malignancies: typical and atypical ultrasound features. Korean J Radiol. 2014; 15(1):20-8. PMC: 3909857. DOI: 10.3348/kjr.2014.15.1.20. View

2.
Bohman L, Bassett L, Gold R, VOET R . Breast metastases from extramammary malignancies. Radiology. 1982; 144(2):309-12. DOI: 10.1148/radiology.144.2.7089284. View

3.
Pal S, Lau S, Kruper L, Nwoye U, Garberoglio C, Gupta R . Papillary carcinoma of the breast: an overview. Breast Cancer Res Treat. 2010; 122(3):637-45. PMC: 3244819. DOI: 10.1007/s10549-010-0961-5. View

4.
Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S . Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. J Clin Imaging Sci. 2012; 2:21. PMC: 3352608. DOI: 10.4103/2156-7514.95435. View

5.
Bitencourt A, Graziano L, Osorio C, Guatelli C, Souza J, Mendonca M . MRI Features of Mucinous Cancer of the Breast: Correlation With Pathologic Findings and Other Imaging Methods. AJR Am J Roentgenol. 2016; 206(2):238-46. DOI: 10.2214/AJR.15.14851. View